Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs.
Adverse drug reaction (ADR) is one of the major causes of failure in drug development. Severe ADRs that go undetected until the post-marketing phase of a drug often lead to patient morbidity. Accurate prediction of potential ADRs is required in the entire life cycle of a drug, including early stages of drug design, different phases of clinical trials, and post-marketing surveillance.
Author(s): Liu, Mei, Wu, Yonghui, Chen, Yukun, Sun, Jingchun, Zhao, Zhongming, Chen, Xue-wen, Matheny, Michael Edwin, Xu, Hua
DOI: 10.1136/amiajnl-2011-000699